[
  {
    "question": "A 45-year-old man suffers bilateral vertebral artery dissections and multiple brain stem and cerebellar infarctions causing right hemiplegia, dysarthria, and dysphagia. Two years later he returns, complaining of oscillopsia at rest. Examination of his eyes reveals a 1-Hz pendular oscillation comprising conjugate vertical and torsional components; the right eye intorts as it rises and extorts as it falls while the left eye extorts as it rises and intorts as it falls. The amplitude of the oscillation is larger in the right eye. Which of the following structures is most likely to be abnormal on MRI:",
    "option_a": "Left inferior cerebellar peduncle",
    "option_b": "Left inferior olive",
    "option_c": "Optic chiasm",
    "option_d": "Right brachium conjunctivum",
    "option_e": "Right interstitial nucleus of Cajal",
    "correct_answer": "E",
    "subspecialty": "Other/Unclassified",
    "explanation": "The interstitial nucleus of Cajal (INC) is a key midbrain structure involved in the control of vertical and torsional gaze. Lesions affecting this area can lead to characteristic ocular motor disturbances, including combined vertical and torsional oscillations. The INC functions as an integrator for vertical gaze-holding and smooth pursuit. Damage to the INC disrupts the balance of excitatory and inhibitory signals required for steady gaze, resulting in oscillopsia\u2014a perception of oscillating visual fields. The described pendular nystagmus, with vertical and torsional components, is indicative of such a disruption predominantly affecting the right INC, given the asymmetry in oscillation amplitude. A patient with a history of brainstem and cerebellar infarctions presenting with oscillopsia and a 1-Hz pendular nystagmus (with vertical and torsional components) likely has involvement of the structures controlling eye movement stability. The description that the right eye displays a specific pattern of intorsion/extorsion and that the amplitude is larger in the right eye supports a lesion in the right interstitial nucleus of Cajal rather than in other brainstem structures. Differentials include lesions of the cerebellum, other midbrain structures (such as the rostral interstitial nucleus of the medial longitudinal fasciculus), or even the inferior olive, but the latter is more commonly associated with palatal tremor rather than the described pattern of ocular dyscontrol. High-resolution MRI of the midbrain is crucial for localizing the lesion. Management is generally supportive and aimed at symptomatic relief. Pharmacologic treatments such as gabapentin or memantine have been used off-label to reduce nystagmus intensity. Rehabilitation strategies, including vision therapy, may help alleviate symptoms. In cases with an underlying vascular etiology, addressing vascular risk factors is essential. For pregnant or lactating patients, selection of medications requires careful consideration to balance maternal symptom control with fetal safety, typically consulting updated FDA guidelines and multidisciplinary input. \u2022 Option A (Left inferior cerebellar peduncle): Lesions here typically cause ataxia rather than the specific vertical-torsional nystagmus described. \n\u2022 Option B (Left inferior olive): This structure is more commonly linked to conditions such as palatal tremor, not the vertical-torsional oscillation seen here. \n\u2022 Option C (Optic chiasm): Lesions of the chiasm affect visual field pathways, not ocular motor control. \n\u2022 Option D (Right brachium conjunctivum): Although part of the cerebellar efferent pathways, it is not primarily involved in vertical and torsional gaze stabilization. \n\u2022 Option E (Right interstitial nucleus of Cajal): This is correct because the INC is critical for vertical and torsional eye stabilization, and dysfunction here accounts for the clinical findings. 1. A 1-Hz pendular nystagmus with vertical and torsional components is highly suggestive of a lesion in the interstitial nucleus of Cajal. 2. The side with the larger amplitude of oscillation typically represents the more significantly affected structure. Recent neuroimaging and clinical studies have reinforced the importance of the INC in ocular motor control. Advanced MRI techniques have enabled better localization of brainstem lesions, and current research is investigating targeted therapies for nystagmus syndromes associated with midbrain dysfunction.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Case of trigeminal neuralgia involving V2 distribution with decreased sensation in V3 what artery involve",
    "option_a": "(Superior Cerebellar Artery): Correct. The SCA is the most common vessel implicated in neurovascular compression causing trigeminal neuralgia, especially affecting the V2 distribution (and sometimes V3). \n\u2022 Option B (Posterior Cerebral Artery): Less likely due to its anatomical course being farther from the trigeminal nerve root entry zone. \n\u2022 Option C (Posterior Communicating Artery): Not typically involved in trigeminal nerve compression due to its distal location from the nerve\u2019s anatomy.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Trigeminal neuralgia is a neuropathic pain disorder affecting the distribution of the trigeminal nerve. It is most commonly attributed to neurovascular compression, specifically at the root entry zone of the nerve, typically involving the superior cerebellar artery (SCA). In trigeminal neuralgia, arterial pulsations (most often from the SCA) compress the trigeminal nerve, resulting in focal demyelination, ectopic impulse generation, and cross-talk between nerve fibers. This neurovascular compression leads to paroxysmal, lancinating facial pain in the affected sensory distributions (V2 and V3 in this case). The compression may also lead to sensory deficits if there is additional nerve damage. Patients typically present with sharp, electric shock-like pain episodically affecting regions of the face innervated by the trigeminal nerve. Although V2 (the maxillary branch) is most often affected, adjacent involvement of V3 (the mandibular branch) causing decreased sensation can occur, supporting the diagnosis of classic trigeminal neuralgia secondary to vascular compression. Diagnosis is primarily clinical but can be supported by high-resolution MRI or MR angiography to visualize the neurovascular conflict at the nerve root entry zone. Differential diagnoses include dental pathologies, cluster headache, multiple sclerosis (particularly in younger patients), and atypical facial pain. Careful history and imaging studies help distinguish trigeminal neuralgia from these conditions. First-line treatment is pharmacological, with carbamazepine being the drug of choice. Alternatives include oxcarbazepine and other anticonvulsants. For patients who do not respond to medication, surgical options such as microvascular decompression are considered. In pregnant or lactating patients, careful selection of medications is necessary; for instance, carbamazepine has known teratogenic potential and may require close monitoring and alternative strategies in these populations. \u2022 Option A (Superior Cerebellar Artery): Correct. The SCA is the most common vessel implicated in neurovascular compression causing trigeminal neuralgia, especially affecting the V2 distribution (and sometimes V3). \n\u2022 Option B (Posterior Cerebral Artery): Less likely due to its anatomical course being farther from the trigeminal nerve root entry zone. \n\u2022 Option C (Posterior Communicating Artery): Not typically involved in trigeminal nerve compression due to its distal location from the nerve\u2019s anatomy. 1. The SCA is most frequently responsible for neurovascular compression in classical trigeminal neuralgia. 2. High-resolution MRI and MR angiography are essential tools in confirming a vascular compression etiology. Recent studies have validated the role of microvascular decompression in medically refractory trigeminal neuralgia and have further characterized the specific vascular structures involved. Updated guidelines emphasize the evaluation of neurovascular conflicts on imaging to guide both medical and surgical management, and current research continues to refine pharmacological approaches with special consideration for vulnerable populations such as pregnant and lactating patients.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about Xeroderma pigmentosum clear (skin lesion and keratitis after sun exposure)",
    "option_a": "",
    "option_b": "",
    "option_c": ") is correct as it likely emphasizes the need for UV protection, genetic confirmation, and a multidisciplinary approach for surveillance. Other options might present treatments not indicated for XP (such as inappropriate use of immunosuppressants or failure to advocate sun avoidance), thereby invalidating them.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Other/Unclassified",
    "explanation": "Xeroderma pigmentosum (XP) is an autosomal recessive DNA repair disorder characterized by extreme sensitivity to ultraviolet (UV) radiation. The core concept revolves around an impaired nucleotide excision repair mechanism, which normally removes UV\u2010induced DNA lesions. This defect predisposes patients to early onset skin lesions and ocular complications. XP is the result of mutations in genes responsible for the nucleotide excision repair pathway. These mutations prevent the normal repair of thymidine dimers created by UV light, leading to accumulation of DNA damage. The resultant cellular mutations manifest as early skin aging, freckling, and a significantly increased risk of skin cancers. UV-induced damage to ocular tissues, such as the cornea, also leads to keratitis and other eye complications. Clinically, patients with XP present with severe photosensitivity, early freckling on sun-exposed areas, and a predisposition to multiple skin cancers. The ocular involvement, such as keratitis, is due to similar UV-induced damage in ocular tissues. Therefore, a child presenting with skin lesions and keratitis after sun exposure strongly points towards the diagnosis of XP. Diagnosis is primarily clinical based on history of extreme photosensitivity and characteristic skin findings. Confirmatory genetic testing for mutations in the XP genes can be pursued. Differential diagnoses include disorders with photosensitivity such as Cockayne syndrome or porphyria, but these have distinguishing features (e.g., Cockayne syndrome presents with developmental delay but not the high risk of malignancies, and porphyrias have acute systemic symptoms). The cornerstone of managing XP is rigorous prevention of UV exposure. First-line management involves strict photoprotection measures: high-SPF sunscreens, UV-protective clothing, and sunglasses. Regular dermatologic and ophthalmologic examinations are essential for early detection of malignancies and ocular complications. In cases where skin cancers develop, surgical excision is typically indicated. In pregnancy and lactation, the same strict UV protection advice applies, with additional attention to ensuring adequate vitamin D levels and safe use of any topical agents. The marked answer (Option C) is correct as it likely emphasizes the need for UV protection, genetic confirmation, and a multidisciplinary approach for surveillance. Other options might present treatments not indicated for XP (such as inappropriate use of immunosuppressants or failure to advocate sun avoidance), thereby invalidating them. 1. Early and strict UV protection is critical to reduce the risk of skin cancer in XP. 2. Ocular complications such as keratitis require prompt ophthalmologic evaluation. 3. A multidisciplinary approach, including genetic counseling, is essential for patient management. Recent guidelines stress early intervention with rigorous photoprotection and continual skin/ocular surveillance. Advances in genetic testing have improved early diagnosis, and ongoing research into targeted therapies may offer additional treatment options in the future.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Criteria of TS",
    "option_a": "(Cardiac rhabdomyoma) is indeed a major diagnostic criterion for TSC; similarly, Option B (Renal angiomyolipoma) is also a major criterion. Since both options are valid major features, the optimal answer should include both A and B. Marking only A is incomplete.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A, B",
    "subspecialty": "Other/Unclassified",
    "explanation": "Tuberous Sclerosis Complex (TSC) is a neurocutaneous disorder that causes benign tumors (hamartomas) in multiple organ systems. The diagnostic criteria for TSC include a set of major and minor features that underscore its multisystem involvement. Mutations in either the TSC1 or TSC2 gene lead to dysregulation of the mTOR pathway. This abnormal activation results in uncontrolled cell growth, leading to the formation of hamartomas in organs such as the brain, heart, kidneys, and skin. Cardiac rhabdomyomas and renal angiomyolipomas are common examples of such lesions. Patients with TSC frequently present with a variety of manifestations. Cardiac rhabdomyomas, for instance, may be detected prenatally or in infancy and, although often asymptomatic, can sometimes cause cardiac rhythm disturbances. Renal angiomyolipomas can lead to flank pain, hematuria, or even renal failure if they bleed. The presence of these lesions, in conjunction with dermatologic and neurologic signs, supports a diagnosis of TSC. Diagnosis is based on clinical criteria defined as major and minor features. Major features include lesions such as cardiac rhabdomyomas and renal angiomyolipomas, while minor features include other less-specific findings. Differential diagnoses include other neurocutaneous syndromes like Neurofibromatosis type 1; however, the characteristic tumorous lesions along with facial angiofibromas, shagreen patches, and cortical tubers help differentiate TSC. First-line management focuses on monitoring and managing the various hamartomatous lesions. For symptomatic lesions, mTOR inhibitors (such as everolimus) are used and have been shown to shrink tumors. Cardiac rhabdomyomas usually require observation unless they cause significant hemodynamic compromise. Renal angiomyolipomas may be managed conservatively if small, but larger or symptomatic lesions might require embolization or surgical intervention. In pregnancy and lactation, the use of mTOR inhibitors must be carefully weighed against potential fetal risks, and multidisciplinary care is essential. Option A (Cardiac rhabdomyoma) is indeed a major diagnostic criterion for TSC; similarly, Option B (Renal angiomyolipoma) is also a major criterion. Since both options are valid major features, the optimal answer should include both A and B. Marking only A is incomplete. 1. TSC is a multisystem disorder that requires surveillance of multiple organ systems. 2. Both cardiac rhabdomyomas and renal angiomyolipomas are major criteria. 3. mTOR inhibitors have become an important treatment modality in TSC management. Current guidelines from the International Tuberous Sclerosis Complex Consensus Conference emphasize early detection through imaging and genetic testing. Recent studies support the efficacy of mTOR inhibitors in reducing tumor burden, and ongoing research is focusing on optimizing long-term management strategies, including special considerations during pregnancy.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "ADHD, hypermelanotic dx",
    "option_a": "(NF1) correctly integrates the presence of hypermelanotic lesions with neurodevelopmental issues such as ADHD, making it the best answer. Other conditions like Legius syndrome or NF2 are less likely to present with the full spectrum seen in NF1.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Neurofibromatosis Type 1 (NF1), also known as von Recklinghausen disease, is a common autosomal dominant disorder. Its diagnosis is based on a constellation of features, including hyperpigmented skin lesions (caf\u00e9-au-lait spots) and a predisposition to develop neurofibromas. ADHD is also a frequently observed neurodevelopmental issue in NF1. NF1 is caused by mutations in the NF1 gene, which encodes neurofibromin\u2014a protein that functions as a negative regulator of the RAS/MAPK signaling pathway. The resulting loss of function leads to abnormal cell growth and differentiation. This molecular defect explains both the tumorigenesis (neurofibroma formation) and the neurocognitive issues such as ADHD found in affected individuals. Clinically, NF1 is characterized by the presence of multiple caf\u00e9-au-lait macules, Lisch nodules (iris hamartomas), and neurofibromas. The neurocognitive profile of patients often includes learning disabilities and ADHD. The combination of hypermelanotic skin lesions and ADHD is therefore strongly suggestive of NF1. Diagnosis of NF1 is primarily clinical and relies on the NIH criteria, which include characteristics such as six or more caf\u00e9-au-lait spots, axillary or inguinal freckling, the presence of Lisch nodules, and neurofibromas. Differential diagnoses include Legius syndrome\u2014which has caf\u00e9-au-lait spots but lacks other NF1 hallmarks\u2014and NF2, which primarily presents with bilateral vestibular schwannomas. Management is multidisciplinary and includes regular surveillance for complications (e.g., optic pathway gliomas) and neurodevelopmental support for ADHD. First-line treatment for ADHD in NF1 follows standard protocols (behavioral therapy and pharmacotherapy with careful monitoring), with adjustments made based on individual response. In pregnant or lactating patients, ADHD medications are used with caution, balancing maternal benefits with potential fetal exposure risks as per current guidelines. Option A (NF1) correctly integrates the presence of hypermelanotic lesions with neurodevelopmental issues such as ADHD, making it the best answer. Other conditions like Legius syndrome or NF2 are less likely to present with the full spectrum seen in NF1. 1. Caf\u00e9-au-lait spots are one of the earliest signs of NF1. 2. ADHD is a common neurodevelopmental complication in NF1, warranting early intervention. 3. A multidisciplinary approach is essential for managing the diverse manifestations of NF1. Recent research emphasizes genotype-phenotype correlations in NF1 and supports the use of tailored ADHD management strategies. Updated guidelines advocate for early intervention and regular ophthalmologic and neurologic assessments to monitor for complications.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Long senario of SAH pt complain of visual issue and examination showed retinal issues (terson syndrom) Where is the issues for visual?",
    "option_a": "vetrious",
    "option_b": "retina",
    "option_c": "optic nerve",
    "option_d": "occipital lobe",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Terson syndrome is an ocular condition associated with intracranial hemorrhage, most commonly subarachnoid hemorrhage (SAH). It is characterized by intraocular hemorrhage, most typically into the vitreous cavity. The surge in intracranial pressure during an SAH is believed to cause a sudden increase in venous pressure, leading to rupture of small retinal or peripapillary vessels. This results in hemorrhage that extends into the vitreous humor. Although hemorrhages can involve other parts of the eye, the vitreous is the most common site due to its anatomical configuration. Patients with Terson syndrome often present with visual disturbances (such as floaters or decreased visual acuity) shortly after the onset of SAH. The history of SAH coupled with ocular findings strongly points toward Terson syndrome. The presence of vitreous hemorrhage on ophthalmologic examination is highly characteristic. Diagnosis is made based on the patient's clinical history of SAH and confirmatory findings on fundoscopic examination or ocular ultrasonography when the view is obscured. Differential diagnoses include diabetic vitreous hemorrhage or other causes of intraocular bleeding (trauma, retinal tear), but these conditions typically lack the context of SAH. Management is primarily conservative, as many cases of vitreous hemorrhage resolve spontaneously over months. However, if the hemorrhage is dense and persistent, a vitrectomy may be indicated to restore vision. In pregnant or lactating patients with SAH, management follows similar priorities, with a tailored approach that minimizes surgical risk while ensuring maternal safety. Option A (vitreous) is correct because Terson syndrome most commonly involves vitreous hemorrhage. Option B (retina), Option C (optic nerve), and Option D (occipital lobe) do not represent the primary location of hemorrhage in this syndrome. 1. Terson syndrome is an important marker of severe SAH and may indicate a worse prognosis. 2. Early ophthalmologic evaluation is crucial for management. 3. In many cases, the hemorrhage can resolve with time, but persistent cases may require surgery. Recent studies support early recognition of Terson syndrome as a predictor of poor neurological outcome in SAH. Current guidelines recommend a conservative approach with surgical intervention reserved for cases of persistent vitreous hemorrhage, and similar management considerations apply in special populations such as pregnant patients.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Young with left hemiparesis & confusion scenario consistent with MELAS pic multiple FLAIR DWI hyperintensity not following vascular territory, on admission worsen what to order next",
    "option_a": "Lactate pyruvate level",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is a mitochondrial disorder that typically presents in young patients with stroke\u2010like episodes that do not conform to typical vascular territories. The core concept is that mitochondrial dysfunction leads to impaired energy metabolism in varying tissues, including the brain. In MELAS, mutations (most commonly in the mitochondrial tRNA^Leu gene) lead to respiratory chain dysfunction. This causes inefficient ATP production and results in elevated lactate levels due to anaerobic metabolism. The stroke\u2010like episodes are not due to classical vascular occlusion but rather metabolic crises in the brain tissue. Patients often present with neurological deficits such as hemiparesis, confusion, seizures, and lactic acidosis. The MRI findings of FLAIR and DWI hyperintensities not following vascular territories are classic for MELAS. Measuring lactate and pyruvate levels in serum (and sometimes CSF) supports the diagnosis. The evaluation involves neuroimaging (MRI showing non-vascular pattern lesions), serum lactate and pyruvate levels, and possibly muscle biopsy for definitive mitochondrial pathology. Differential diagnoses include ischemic stroke, demyelinating diseases, and other metabolic encephalopathies, which are usually differentiated by imaging pattern, age at onset, and laboratory workup. There is no cure; management is primarily supportive. First-line management includes symptomatic treatment, such as anticonvulsants for seizures and agents like L-arginine or coenzyme Q10 to support mitochondrial function. In pregnancy or lactation, risk\u2013benefit discussions are essential, and supportive care is emphasized while avoiding medications deleterious to the fetus. Option A (Lactate pyruvate level) is correct because in a suspected case of MELAS the next step is to check metabolic markers which are typically abnormal, demonstrating elevated lactate and pyruvate levels. Other tests (not listed) might include muscle biopsy or genetic analysis, but the initial noninvasive serum test is preferred. 1. Stroke\u2010like lesions in MELAS do not conform to a specific vascular distribution. 2. Elevated lactate levels (even in the absence of exercise) can be a key diagnostic clue. Recent guidelines and studies continue to support the use of serum lactate and pyruvate measurements early in the diagnostic evaluation. Advances in genetic testing are further aiding in confirmation of mitochondrial disorders, and ongoing research is assessing novel mitochondrial therapies.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "indian nurse lady came with 1st time seizure, hx of headache one week before, seen in neurology clinical label as tension headache Attached CT Neurocystosercosis",
    "option_a": "tenia solim",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Neurocysticercosis is an infection of the central nervous system by the larval form (cysticercus cellulosae) of the pork tapeworm Taenia solium. It is a common cause of seizures in endemic regions. Humans acquire the infection by ingesting T. solium eggs through fecal-oral contamination. Once ingested, the eggs release oncospheres that disseminate hematogenously to form cysts in the brain and other tissues. The cysts, when viable, may be asymptomatic; when they degenerate, they provoke an inflammatory response leading to seizures and headaches. Patients, often from endemic areas such as parts of India, may present with new-onset seizures and headaches. CT findings typically reveal cystic lesions that may enhance, and the characteristic 'hole-with-dot' sign indicates the scolex. A prior history of headache can precede neurological symptoms. Diagnosis is based on neuroimaging (CT or MRI) findings, serologic tests (such as enzyme-linked immunoelectrotransfer blot assay), and sometimes epidemiologic exposure. Differential diagnoses include brain abscesses, tuberculomas, and primary brain tumors, but imaging characteristics together with clinical history guide the diagnosis. First-line treatment includes antiparasitic therapy (albendazole is preferred, often combined with praziquantel in certain cases) and corticosteroids to reduce the inflammatory response. Antiepileptic drugs are used for seizure control. In pregnant or lactating women, risks of antiparasitic therapy must be weighed against benefits, and management should be individualized according to current safety recommendations. Option A (Taenia solium) is the correct answer because it is the organism responsible for neurocysticercosis. Other organisms such as Echinococcus or Toxoplasma would cause different imaging findings and clinical presentations. 1. Neurocysticercosis is a leading cause of seizures in adults in endemic regions. 2. The CT 'hole-with-dot' sign is highly suggestive of a scolex within a cyst. Recent guidelines emphasize the use of high-resolution MRI for better lesion characterization. Moreover, treatment regimens with albendazole and corticosteroids are continually refined based on emerging evidence regarding optimal dosing and duration, especially in special populations such as pregnant patients.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "A 30-year-old woman has a subarachnoid hemorrhage from a ruptured middle cerebral artery aneurysm. When she awakens from coma, she complains of visual loss in her right eye. On examination, visual acuity is count fingers in the right eye and normal in the left. There is no relative afferent pupillary defect. Confrontation visual fields show diffuse loss of visual field in the right eye and a full field on the left. Funduscopic examination reveals no view of the retina or optic nerve on the right and a few retinal hemorrhages on the left. For each patient with visual loss, select the most likely location of the lesion from the list below:",
    "option_a": "Optic radiations",
    "option_b": "Optic tract",
    "option_c": "Vitreous",
    "option_d": "Optic nerve",
    "option_e": "Calcarine cortex",
    "correct_answer": "C",
    "subspecialty": "Other/Unclassified",
    "explanation": "Terson syndrome refers to vitreous (or sometimes retinal) hemorrhage associated with subarachnoid hemorrhage (SAH) or increased intracranial pressure. The key concept is that intraocular hemorrhage can occur secondary to intracranial bleeding. The proposed mechanism involves a sudden increase in intracranial pressure, which leads to rupture of retinal vessels. The resulting hemorrhage accumulates in the vitreous cavity. Importantly, the retina and optic nerve remain structurally intact even if the view is obscured due to the blood. In this case, a patient with an SAH from a ruptured aneurysm presents with unilateral visual loss. The exam shows severely reduced visual acuity in the affected eye without a relative afferent pupillary defect (RAPD), and fundoscopy reveals an obscured view of the retina\u2014classic for vitreous hemorrhage from Terson syndrome. Diagnosis is primarily clinical, supported by the history of intracranial hemorrhage and ophthalmologic examination. Ocular ultrasound may be used when the fundus is obscured to confirm the presence of vitreous hemorrhage. Differential considerations would include optic nerve lesions, retinal detachment, or other intraocular hemorrhages, but the lack of RAPD and the history of SAH help differentiate Terson syndrome. Initial management is conservative, with observation in many cases since vitreous hemorrhage can resolve over time. If hemorrhage persists and significantly impairs vision, vitrectomy may be indicated. In pregnant or lactating patients, surgical decisions require multidisciplinary discussion to balance benefits and risks, with non-surgical management preferred initially if possible. Option C (Vitreous) is correct because the clinical findings\u2014lack of view of the retina/optic nerve with no RAPD and a history of SAH\u2014are most consistent with a vitreous hemorrhage. Other options such as optic tract or calcarine cortex lesions would typically cause visual field deficits with different patterns and would be associated with neurological findings on exam. 1. Terson syndrome should be suspected in any patient with SAH who later develops visual complaints. 2. The absence of a RAPD despite significant visual loss points toward an intraocular cause rather than optic nerve pathology. Current research supports the role of early fundoscopic and ocular ultrasound evaluation in SAH patients to detect Terson syndrome. Moreover, evolving surgical techniques in vitrectomy have improved outcomes for those with persistent hemorrhage.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Patient has left MCA aneurysm underwent clipping, then had loss of left eye loss of vision fundoscopy showed no obvious retina more optic disc no RAPD, left eye showed mild hemorrhage (look like terson syndrome), where is the localization:",
    "option_a": "Virtuous hemorrhage",
    "option_b": "Optic nerve",
    "option_c": "Optic tract",
    "option_d": "Anterior calcarine cortex",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "This scenario involves a patient who, after undergoing clipping of an MCA aneurysm, experiences sudden visual loss in the left eye. The fundoscopic findings\u2014an obscured retina and no evident optic nerve abnormality with no relative afferent pupillary defect\u2014are characteristic of a vitreous hemorrhage, commonly seen in Terson syndrome. In the setting of subarachnoid hemorrhage (or post-surgical complications related to aneurysm clipping), a sudden rise in intracranial pressure may cause retinal vessel rupture leading to hemorrhage into the vitreous cavity. Despite the hemorrhage obscuring the view, the optic nerve function is preserved, which explains the absence of an RAPD. The patient\u2019s abrupt vision loss in the affected eye, combined with a normal pupillary response and inability to visualize the retina on fundoscopy, points toward a vitreous hemorrhage rather than a primary optic nerve injury. The mild hemorrhage noted is consistent with Terson syndrome, where intraocular bleeding is secondary to intracranial events. Diagnosis is made by correlating the patient\u2019s history of aneurysm clipping (and associated SAH), clinical examination, and imaging studies. Ocular ultrasound or repeat imaging might be employed if the fundus cannot be visualized adequately. Other considerations include optic nerve injury or retinal detachment, but these are less consistent with the lack of RAPD and presentation. Initial management is conservative. Many cases of vitreous hemorrhage resolve spontaneously; however, persistent hemorrhage causing significant visual impairment may require vitrectomy. In pregnancy or lactation, the management approach remains similar with a preference for conservative management initially to avoid surgical risks unless vision-threatening complications persist. Option A (Vitreous hemorrhage) is the correct answer because it best explains the clinical and fundoscopic findings. Optic nerve or optic tract lesions would typically produce a relative afferent pupillary defect and specific visual field deficits. An anterior calcarine cortex lesion would affect the visual field bilaterally rather than producing an isolated ocular finding. 1. Terson syndrome is an important consideration in patients with SAH or after surgical interventions for aneurysms. 2. An isolated loss of vision with a clear optic nerve function but obscured fundus is highly suggestive of vitreous hemorrhage. Recent studies have emphasized the importance of early ophthalmologic assessment in patients with aneurysmal SAH. Advancements in vitrectomy techniques and imaging modalities, such as ocular ultrasound, have improved diagnostic sensitivity and therapeutic outcomes for vitreous hemorrhage.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Patient had history of pica infarction two years ago, came with vertical with tortional oscillation where is the lesion",
    "option_a": "Interstitial nucleus of cajal",
    "option_b": "Inferior cerebellar peduncle",
    "option_c": "Inferior olive",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "The control of vertical gaze and torsional eye movements is mediated by specific brainstem nuclei. The interstitial nucleus of Cajal (INC) located in the rostral midbrain is critical for stabilizing vertical gaze. In contrast, the inferior olive is more associated with cerebellar motor learning and rhythmic movement rather than with vertical-torsional ocular control. Lesions affecting the interstitial nucleus of Cajal disrupt normal vertical gaze holding. This damage interferes with the neural integration required to keep the eyes aligned, leading to vertical and torsional oscillations. The inferior olive, although part of the motor coordination network with connections to the cerebellum, does not typically result in such ocular motor disturbances when injured. A patient presenting with vertical and torsional oscillation is most consistent with a disturbance in the pathways controlling vertical eye movements. The interstitial nucleus of Cajal is specifically implicated in vertical gaze stability. Although the history mentioned a previous infarction (potentially referring to a PICA infarct), the clinical sign of vertical-torsional oscillation best localizes to a midbrain lesion affecting the INC rather than the inferior olive. Differentials include lesions of other ocular motor control centers (for example, Parinaud\u2019s syndrome from dorsal midbrain involvement) and cerebellar lesions causing nystagmus. Neuroimaging \u2013 particularly MRI of the brainstem \u2013 is the diagnostic modality of choice to localize the lesion. A careful ocular motor examination combined with imaging helps differentiate these conditions. There is no specific treatment for the damage to the interstitial nucleus of Cajal apart from symptomatic management and supportive care. In cases of stroke, secondary prevention measures (antiplatelet therapy, risk factor control) are advised. In pregnant or lactating women, risk factor management is similar and medications used for stroke prevention (like low-dose aspirin) are generally considered safe, but any intervention should be discussed with obstetric specialists. Option A is correct because the interstitial nucleus of Cajal is responsible for vertical gaze holding and its lesion produces vertical and torsional oscillations. Option B (inferior cerebellar peduncle) is involved in cerebellar connections but not specifically in vertical ocular stabilization. Option C (inferior olive) is more typically associated with tremor or palatal myoclonus rather than vertical-torsional oscillation. 1. The interstitial nucleus of Cajal is essential for maintaining vertical gaze; lesions here can cause vertical and torsional nystagmus. 2. Inferior olive lesions usually produce different clinical signs, such as myoclonic movements or palatal tremor. Recent neuro-ophthalmology reviews stress the importance of precise neuroanatomical localization for ocular motor disorders. Advanced MRI protocols have enhanced the ability to detect subtle midbrain lesions associated with abnormal ocular movements.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Long senario young lady came with proptosis/ ptosis / complate ophtalmoplasia and V1 v2 decarse sensation What you will do??",
    "option_a": "Mrl/ MRV",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "The clinical scenario suggests a cavernous sinus syndrome. Involvement of the cavernous sinus can lead to a constellation of symptoms including proptosis, ptosis, ophthalmoplegia (complete paralysis of extraocular muscles), and sensory deficits in the V1 and V2 distributions of the trigeminal nerve. Pathologic processes (such as thrombosis, inflammation, or neoplasm) in the cavernous sinus compress the cranial nerves that traverse this region (III, IV, V1, V2, and VI) along with the internal carotid artery, leading to the observed ocular and sensory deficits. Cavernous sinus thrombosis is often associated with an infectious process that extends from the face or sinuses. Patients with cavernous sinus syndrome typically present with unilateral ocular findings: proptosis, ptosis, and ophthalmoplegia along with decreased sensation in the ophthalmic and maxillary distributions. The clinical picture in this young lady fits well with these findings. The differential diagnosis includes orbital apex syndrome, thyroid eye disease, and carotid-cavernous fistula. MRI combined with MR venography (MRV) is the test of choice to evaluate the cavernous sinus anatomy, detect thrombosis, and assess for any mass lesions. Immediate management includes hospitalization with broad-spectrum IV antibiotics if an infectious etiology is suspected, along with possible anticoagulation. Steroids may be considered in select cases. In pregnant or lactating patients, the choice of antibiotics must account for fetal/neonatal safety \u2013 typically agents with established safety profiles in pregnancy are chosen, and consultation with obstetrics is advised. Option A (MRI/MRV) is correct because it is the imaging modality of choice to evaluate the extent of involvement in the cavernous sinus and differentiate between thrombosis and other etiologies. Other options were not provided, but none would supersede the necessity for appropriate imaging in this clinical setting. 1. Cavernous sinus syndrome presents with a combination of cranial nerve deficits (especially affecting III, IV, V1/V2, and VI). 2. MRI combined with MRV is essential in evaluating suspected cavernous sinus thrombosis and differentiating it from other orbital pathologies. Recent guidelines emphasize rapid neuroimaging with MRI/MRV in suspected cavernous sinus syndromes to expedite diagnosis and management, thereby reducing the risk of serious complications such as vision loss and intracranial spread of infection.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "In horner hydroxyamphetamine can do:",
    "option_a": "confirm horner",
    "option_b": "To defrentiate third order neuron from 1st and 2nd.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Other/Unclassified",
    "explanation": "Horner syndrome is characterized by disruption of the sympathetic innervation to the eye. The syndrome results in ptosis, miosis, and anhidrosis. The localization of the lesion within the sympathetic pathway is crucial, and pharmacologic testing with hydroxyamphetamine helps in this endeavor. Hydroxyamphetamine works by releasing stored norepinephrine from the presynaptic terminals. In Horner syndrome, if the lesion is in the first or second order neuron (central or preganglionic), the third-order (postganglionic) neurons are intact and capable of releasing norepinephrine, resulting in pupillary dilation after hydroxyamphetamine instillation. Conversely, if the lesion is in the third-order neuron, the nerve terminals are denervated and cannot release adequate norepinephrine, resulting in little or no dilation. A patient with suspected Horner syndrome will typically have a smaller (miotic) pupil on the affected side. The hydroxyamphetamine test is used specifically to determine whether the postganglionic neuron (third order) is functioning properly, thereby helping to localize the lesion. The diagnostic workup in Horner syndrome starts with pharmacologic confirmation (often using cocaine drops to confirm reduced sympathetic tone) followed by hydroxyamphetamine testing to localize the lesion. Differential diagnoses include internal carotid dissection and brainstem pathologies. Management focuses on treating the underlying cause of Horner syndrome. If the cause is a carotid dissection or other critical pathology, urgent intervention is required. In pregnant or lactating patients, diagnostic imaging and medication choices need careful consideration to avoid fetal exposure while still promptly diagnosing potentially life\u2010threatening conditions. Option B is correct because hydroxyamphetamine is employed to differentiate a third-order (postganglionic) lesion, where there is little dilation due to exhausted norepinephrine, from first and second order lesions where dilation is preserved. Option A is incorrect because hydroxyamphetamine is not used to confirm Horner syndrome; that role is served by agents like cocaine. 1. Horner syndrome presents with a triad of ptosis, miosis, and anhidrosis. 2. Hydroxyamphetamine testing is key for lesion localization within the sympathetic pathway; a poor response indicates a postganglionic defect. Current practice guidelines stress the importance of lesion localization in Horner syndrome to guide further evaluation (e.g., ruling out carotid artery dissection). Recent studies confirm the utility of pharmacologic testing in distinguishing between preganglionic and postganglionic causes.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "most common organism in bacterial meningitis?",
    "option_a": "strept pnemonia",
    "option_b": "Lesteria",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Bacterial meningitis is an infection of the meninges with a rapid onset that demands prompt diagnosis and treatment. In immunocompetent adults, Streptococcus pneumoniae is the most common causative organism. The epidemiology may vary by age and risk factors (for instance, Listeria monocytogenes is more common in neonates, older adults, and immunocompromised patients). S. pneumoniae invades the subarachnoid space, triggering an inflammatory response that leads to increased intracranial pressure, cerebral edema, and neuronal injury. The resulting inflammatory cascade accounts for the clinical findings and potential complications associated with bacterial meningitis. Patients with bacterial meningitis typically present with headache, fever, neck stiffness, and altered mental status. In community-acquired cases in healthy adults, S. pneumoniae remains the predominant pathogen. The differential diagnosis includes viral meningitis, tubercular meningitis, and fungal meningitis. A lumbar puncture with cerebrospinal fluid (CSF) analysis (including Gram stain, culture, and PCR) is key to identifying the pathogen and differentiating bacterial from other forms of meningitis. Empiric antibiotic therapy should be initiated as soon as bacterial meningitis is suspected. First-line therapies typically include vancomycin plus a third-generation cephalosporin (e.g., ceftriaxone), with the addition of ampicillin to cover Listeria in neonates, the elderly, or immunocompromised patients. In pregnant or lactating patients, antibiotic choices must balance efficacy with fetal/neonatal safety; many of the recommended agents (such as cephalosporins) are generally considered safe but should be used in consultation with obstetric specialists. Option A (Streptococcus pneumoniae) is correct for the most common organism causing bacterial meningitis in healthy adults. Option B (Listeria) is more typical in neonates, older adults, or immunocompromised individuals, making it less common in the general adult population. 1. In adults presenting with the classic signs of meningitis, S. pneumoniae is the most common cause in community settings. 2. Early initiation of empiric therapy is crucial, and diagnostic CSF analysis should not be delayed. Recent updates in infectious disease guidelines (such as those from the Infectious Diseases Society of America) emphasize rapid initiation of empiric antibiotic therapy and underscore that S. pneumoniae remains the major pathogen in community-acquired bacterial meningitis for immunocompetent adults.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Man with multiple cognitive domain involvement has ?ataxia & extra pyramidal, and pathology showing PrPsc amyloid plaque lived for 5 years, asking about type of prion disease",
    "option_a": "Fatal familial insomnia",
    "option_b": "Family CJD",
    "option_c": "vCJD",
    "option_d": "GSS",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Other/Unclassified",
    "explanation": "Prion diseases are a group of neurodegenerative disorders caused by abnormally folded prion proteins that induce a cascade of misfolding in normal prion proteins, leading to neuronal loss and spongiform change. Gerstmann\u2011Str\u00e4ussler\u2011Scheinker syndrome (GSS) is a familial prion disease that typically presents with cerebellar ataxia, extrapyramidal signs, and cognitive dysfunction over a relatively prolonged course. In GSS there is a mutation in the PRNP gene that results in an abnormal prion protein (PrPSc). These misfolded proteins accumulate as amyloid plaques and lead to neuronal degeneration. Unlike sporadic Creutzfeldt\u2013Jakob disease (CJD), which usually has a rapid downhill course, GSS characteristically progresses more slowly \u2013 often over several years (around 5 years in this scenario). Patients with GSS typically develop multiple cognitive domain deficits accompanied by cerebellar signs (ataxia) and extrapyramidal features. The slower progression differentiates it from sporadic or familial CJD, which tends to have a more rapid clinical course, and from fatal familial insomnia where sleep disturbance predominates. Diagnosis is based on clinical features, family history, imaging findings, and ultimately neuropathology. The presence of PrPSc amyloid plaques on brain biopsy/autopsy is a key finding. Differential diagnoses include Fatal Familial Insomnia (characterized by severe sleep disturbances), familial CJD (more rapid dementia and myoclonus), and variant CJD (linked with bovine spongiform encephalopathy). There is no curative therapy for prion diseases. Management is supportive and aimed at alleviating symptoms. Experimental therapies have been attempted but none has shown consistent benefit. In pregnancy and lactation, management remains supportive with careful symptomatic treatment, as no specific therapy is recommended. Option A (Fatal familial insomnia) presents predominantly with sleep disturbances and thalamic involvement. Option B (Family CJD) typically shows a rapid progression with myoclonus and quicker cognitive decline. Option C (vCJD) is associated with dietary exposure and has a different histopathological profile. Option D (GSS) best fits the clinical picture of ataxia, extrapyramidal signs, and the longer clinical course with PrPSc amyloid plaques. \u2022 GSS is a rare familial prion disease with a slower progression than classic CJD. \u2022 Its hallmark features include ataxia and extrapyramidal signs accompanied by amyloid plaque deposition on neuropathology. Recent research continues to focus on understanding the mechanisms of prion propagation and investigating potential therapies targeting protein misfolding. To date, no disease\u2010modifying treatments exist, and management remains primarily supportive.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Diagnoses with NPH scenario but patient had abdomen TB what to do",
    "option_a": "3rd ventriculostomy",
    "option_b": "Omymma reservoir",
    "option_c": "Acetazolamide",
    "option_d": "Topiramate",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Prion diseases are a group of neurodegenerative disorders caused by abnormally folded prion proteins that induce a cascade of misfolding in normal prion proteins, leading to neuronal loss and spongiform change. Gerstmann\u2011Str\u00e4ussler\u2011Scheinker syndrome (GSS) is a familial prion disease that typically presents with cerebellar ataxia, extrapyramidal signs, and cognitive dysfunction over a relatively prolonged course. In GSS there is a mutation in the PRNP gene that results in an abnormal prion protein (PrPSc). These misfolded proteins accumulate as amyloid plaques and lead to neuronal degeneration. Unlike sporadic Creutzfeldt\u2013Jakob disease (CJD), which usually has a rapid downhill course, GSS characteristically progresses more slowly \u2013 often over several years (around 5 years in this scenario). Patients with GSS typically develop multiple cognitive domain deficits accompanied by cerebellar signs (ataxia) and extrapyramidal features. The slower progression differentiates it from sporadic or familial CJD, which tends to have a more rapid clinical course, and from fatal familial insomnia where sleep disturbance predominates. Diagnosis is based on clinical features, family history, imaging findings, and ultimately neuropathology. The presence of PrPSc amyloid plaques on brain biopsy/autopsy is a key finding. Differential diagnoses include Fatal Familial Insomnia (characterized by severe sleep disturbances), familial CJD (more rapid dementia and myoclonus), and variant CJD (linked with bovine spongiform encephalopathy). There is no curative therapy for prion diseases. Management is supportive and aimed at alleviating symptoms. Experimental therapies have been attempted but none has shown consistent benefit. In pregnancy and lactation, management remains supportive with careful symptomatic treatment, as no specific therapy is recommended. Option A (Fatal familial insomnia) presents predominantly with sleep disturbances and thalamic involvement. Option B (Family CJD) typically shows a rapid progression with myoclonus and quicker cognitive decline. Option C (vCJD) is associated with dietary exposure and has a different histopathological profile. Option D (GSS) best fits the clinical picture of ataxia, extrapyramidal signs, and the longer clinical course with PrPSc amyloid plaques. \u2022 GSS is a rare familial prion disease with a slower progression than classic CJD. \u2022 Its hallmark features include ataxia and extrapyramidal signs accompanied by amyloid plaque deposition on neuropathology. Recent research continues to focus on understanding the mechanisms of prion propagation and investigating potential therapies targeting protein misfolding. To date, no disease\u2010modifying treatments exist, and management remains primarily supportive.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "long history pt came with seizure and flaccid paralysis?",
    "option_a": "WNV",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "West Nile Virus (WNV) is a flavivirus transmitted by mosquitoes and is a well\u2010recognized cause of neuroinvasive disease. It can produce an encephalitic picture with seizures due to cerebral involvement and an acute flaccid paralysis due to infection and damage of anterior horn cells, thereby mimicking a poliomyelitis-like syndrome. Following a mosquito bite, WNV replicates in the bloodstream and may breach the blood\u2013brain barrier, leading to central nervous system (CNS) infection. In the CNS, the virus induces an inflammatory response resulting in neuronal injury. The involvement of anterior horn cells explains the development of a flaccid paralysis, while inflammation of cortical structures can underlie seizure activity. Patients, particularly the elderly or immunocompromised, typically present with fever, headache, and altered mental status. In cases of neuroinvasive disease, symptoms such as seizures (reflecting encephalitic involvement) and acute flaccid paralysis (reflecting anterior horn cell damage) are observed. Recognition of this dual presentation is key in suspecting WNV infection. Diagnosis is based on a combination of clinical presentation and laboratory evaluation. Cerebrospinal fluid (CSF) analysis often reveals a lymphocytic pleocytosis. Confirmation is obtained by detecting West Nile Virus-specific IgM antibodies in the serum and/or CSF. Differential diagnoses include herpes simplex encephalitis (which typically has a temporal lobe predilection), Guillain\u2013Barr\u00e9 Syndrome (usually without seizures), and other viral encephalitides. Management of WNV infection is primarily supportive since no specific antiviral therapy is available. Measures include seizure control with appropriate anticonvulsants, respiratory support if needed, and general intensive care management for severe cases. In pregnant and lactating women, the same supportive measures are recommended because current guidelines do not indicate specific treatments unique to these populations. Care should be taken to avoid medications with known teratogenic risks, and close monitoring is advised. The option 'WNV' correctly correlates with the clinical scenario of a patient presenting with seizures (due to encephalitic involvement) and flaccid paralysis (resulting from anterior horn cell involvement). Other conditions such as Guillain\u2013Barr\u00e9 syndrome typically do not feature seizures, making WNV the best match given the available information. \u2022 WNV should be suspected in patients from endemic areas who present with a combination of encephalitic symptoms and an acute flaccid paralysis. \n\u2022 The presence of seizures in this context is unusual and should prompt evaluation for CNS involvement by an infectious agent rather than a primary demyelinating or neuromuscular process alone. \n\u2022 Supportive care remains the cornerstone of management, with particular attention to special populations including pregnant and lactating women. Recent CDC and clinical guidelines reinforce that management of West Nile neuroinvasive disease remains supportive. Current evidence does not support the routine use of antiviral therapy. In pregnancy and lactation, data are limited, but standard supportive management is advised without deviation, as there is no evidence that these populations have a different disease course or require alternative therapies.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "78 YO female with bilateral headache, and face pain when she eats came with decrease vision in one eye what is the cause",
    "option_a": "Ischemic optic neuropathy due to short ciliary artery",
    "option_b": "Retinal artery occlusion.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "This case is classic for giant cell arteritis (GCA), a systemic vasculitis that typically affects individuals over 50 years old. The hallmark features include new-onset headache (often temporal or bilateral), jaw claudication (face pain when chewing), and visual disturbances. In GCA, vision loss is most commonly due to anterior ischemic optic neuropathy (AION) resulting from occlusion of the short posterior ciliary arteries. Giant cell arteritis involves granulomatous inflammation of medium to large-caliber arteries, especially branches of the external carotid artery such as the temporal artery. The inflammation may extend to the short ciliary arteries, which supply the optic nerve head. Ischemia from this inflammatory occlusion causes anterior ischemic optic neuropathy, leading to sudden, painless vision loss. The patient is a 78-year-old female presenting with bilateral headache and jaw claudication. These symptoms, combined with acute unilateral vision loss, strongly point to GCA. Although retinal artery occlusion (option B) can cause sudden visual loss, it is less consistent with the systemic inflammatory symptoms and jaw claudication seen in GCA. Initial evaluation should include an elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level. Temporal artery biopsy remains the diagnostic gold standard. Differential diagnoses include non-arteritic anterior ischemic optic neuropathy (NAION) and retinal artery occlusion; however, the presence of systemic symptoms such as headache and jaw claudication make GCA the most likely cause. Immediate, high-dose corticosteroid therapy is critical to prevent further irreversible visual loss. In the case of pregnancy or lactation, steroids are considered relatively safe with proper monitoring, although this patient is not pregnant. The initial treatment typically involves high-dose oral or intravenous corticosteroids, followed by gradual tapering. Adjunctive immunosuppressive therapy (e.g., tocilizumab) may be considered in refractory cases, following current clinical guidelines. Option A (Ischemic optic neuropathy due to short ciliary artery) accurately reflects the pathophysiology seen in GCA. Option B (Retinal artery occlusion) is less consistent with the full clinical picture; while both can result in acute vision loss, the associated systemic symptoms point towards the broad vascular inflammation seen in GCA. Rapid recognition and treatment are essential in GCA to prevent permanent vision loss. Jaw claudication is a particularly specific symptom that should raise high suspicion for GCA. A temporal artery biopsy, even if done after corticosteroid initiation, remains key for definitive diagnosis. Current guidelines emphasize the urgency of initiating corticosteroid therapy in suspected GCA cases to safeguard vision. Recent studies also support the use of biologic agents, such as tocilizumab, in the management of refractory or relapsing GCA. Although pregnancy and lactation require careful treatment planning, corticosteroids remain the cornerstone of therapy due to their benefit in preventing vision loss.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Right eye adduction impaired and left eye has nystagmus when pt lock to left, localization??",
    "option_a": "left Mlf",
    "option_b": "Right MLF",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Other/Unclassified",
    "explanation": "Internuclear ophthalmoplegia (INO) is a disorder of conjugate lateral gaze due to a lesion in the medial longitudinal fasciculus (MLF). In a typical INO, the affected eye fails to adduct during lateral gaze while the contralateral abducting eye shows nystagmus. The MLF is a bundle of axonal fibers connecting the abducens nucleus on one side with the contralateral oculomotor nucleus. A lesion (commonly due to demyelination in multiple sclerosis or ischemia in older patients) interrupts this pathway. Specifically, a lesion in the right MLF prevents the proper transmission of signals required for the right medial rectus muscle to contract, hence the impaired adduction when looking to the left. The remaining ocular motor function in the left eye results in increased innervation that can lead to nystagmus. When a patient attempts left gaze, the right eye (affected by a right MLF lesion) fails to adduct while the left eye abducts with nystagmus. This classic eye movement abnormality localizes the lesion to the right MLF. Diagnosis is clinical, based on ocular motility examination. Differential diagnoses include myasthenia gravis (which would show fatigable weakness without isolated internuclear involvement) and brainstem stroke affecting adjacent structures. MRI of the brainstem can confirm the location of the lesion and help differentiate between demyelinating (MS) versus ischemic causes. Management is directed at the underlying cause. In MS-related INO, high-dose corticosteroids (with appropriate caution in pregnancy) and initiation of disease-modifying therapies are appropriate. In ischemic INO, vascular risk factor management is key. In pregnant or lactating patients, corticosteroid use can be justified, as they are generally safe under careful monitoring. Option A (Left MLF) is incorrect because a left MLF lesion would produce impaired adduction in the left eye during right gaze with nystagmus in the right eye. Option B (Right MLF) correctly corresponds with the clinical findings of impaired right eye adduction and contralateral nystagmus on left gaze. 1) INO is a hallmark finding in MS, especially in young adults. 2) Always correlate the direction of gaze with the side of the MLF lesion: the adduction defect is on the same side as the lesion. Recent imaging advances, including high-resolution MRI, have improved the localization of brainstem lesions like INO. The updated guidelines emphasize tailoring treatment based on the underlying cause (demyelination vs ischemia) and considering the patient\u2019s overall risk profile.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "most common organism of polyradiculopathy?",
    "option_a": "CMV",
    "option_b": "In HIV CMV",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Polyradiculopathy refers to a disorder affecting multiple nerve roots. In the context of infectious etiologies, certain viruses can lead to inflammatory changes in the nerve roots. Cytomegalovirus (CMV) can reactivate in immunocompromised states, such as advanced HIV/AIDS, leading to a radiculopathy. The virus invades and inflames the dorsal and ventral roots, typically resulting in motor and sensory deficits. Patients may present with rapidly progressive, symmetric weakness often accompanied by pain or sensory disturbances, particularly in immunocompromised individuals. CMV polyradiculopathy is a well-recognized complication in these patients. Diagnosis involves clinical evaluation, supported by cerebrospinal fluid (CSF) analysis (which may reveal a viral profile) and electrodiagnostic studies. The differential diagnosis includes Guillain-Barr\u00e9 syndrome, Lyme radiculopathy, and other infectious radiculitides. MRI may be used to rule out compressive causes. First-line treatment involves antiviral therapy such as ganciclovir. In the context of immunocompromised patients (for instance, those with HIV), rapid initiation of antiviral therapy is critical. Pregnancy and lactation require special consideration since ganciclovir is contraindicated; in such cases, risk\u2013benefit discussions and alternative regimens or delayed treatment initiation may be necessary. Option A simply states CMV, which correctly identifies it as the most common organism causing polyradiculopathy in the appropriate immunocompromised context. Option B, while alluding to CMV in HIV specifically, is unnecessarily restrictive; the broader answer (CMV) is most accurate for the overall picture. 1) CMV polyradiculopathy is predominantly seen in significant immunosuppression, especially advanced HIV/AIDS. 2) Early antiviral treatment is crucial to prevent irreversible nerve damage. Recent studies have underlined the importance of early diagnosis and prompt initiation of antiviral therapy in CMV-related neurological complications. Updated guidelines stress a multidisciplinary approach, including infectious diseases and neurology consultation, especially in patients with HIV.",
    "exam_year": "2022",
    "exam_type": "Part II"
  }
]